BioMCP
Specialized solution for precision oncology workflows
Software · Cloud SaaSCompany source
Company profile
About GenomOncology
GenomOncology is a precision oncology platform that transforms complex and fragmented oncology data into actionable intelligence for clinical decision support. The company addresses the unprecedented challenge facing oncology professionals navigating over 1,400 FDA indications and 15,000+ active clinical trials. GenomOncology's platform merges all assay and lab data into unified reports, delivers transparent and explainable AI that generates real-time, auto-generated data interpretations at the point of care, and automates clinical trial matching to customize patient treatment. The platform integrates seamlessly with laboratory information systems (LIS), laboratory information management systems (LIMS), and electronic health records (EHR) for automated, bidirectional data exchange. GenomOncology serves multiple stakeholders in the oncology ecosystem including molecular pathologists, lab technicians, clinical oncologists, clinical trial professionals, bioinformaticians, and clinical researchers. The company's solutions span three core areas: Molecular Pathology Solutions that accelerate reporting and eliminate bottlenecks, Clinical Trial Optimization that ensures patients never miss trial opportunities through real-time matching, and Data Enablement that unlocks the power of oncology data through automated extraction and normalization.
Company description GenomOncology official website
Primary marketPrecision Medicine & Genomics
Commercial modelCommercial information available on request
Work at GenomOncology?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- cancer
- CNS cancer
- oncology
Who it serves
- bioinformaticians
- clinical oncologists
- clinical researchers
- clinical trial professionals
- lab directors
- lab technicians
- molecular pathologists
Deployment & integration
Cloud Saas deployment with recorded integration context.
Recorded integration context: EHR, LIMS, LIS.
Geographic context
MarketsUSA
Company sourceOfficial website
Company milestones
Platform expansion
Strategic partnership with WeTrials announced to accelerate clinical trial enrollment for CNS cancer patients; EHR integration case study demonstrating automation from order to results
Partnerships
Recorded partners
- WeTrials
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Clinical Trial Optimization
Real-time clinical trial matching to never miss patient opportunities
Software · Cloud SaaSCompany source
Data Enablement Solutions
Unlock oncology data with automated extraction and normalization
Platform · Cloud SaaSCompany source
GenomOncology Precision Oncology Platform
Transforms complex and fragmented oncology data into actionable intelligence
Platform · Cloud SaaSCompany source
Molecular Pathology Workbench
Accelerate reporting and eliminate bottlenecks for molecular pathologists
Software · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Development of a comprehensive cardiovascular disease genetic risk assessment test.Genetics in medicine open · Jan 1, 2026
Tackling Non-Small Cell Lung Cancer in Young Adults: From Risk Factors and Genetic Susceptibility to Lung Cancer Profile and Outcomes.American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting · Jun 1, 2024
Development of a comprehensive cardiovascular disease genetic risk assessment test.medRxiv : the preprint server for health sciences · May 9, 2024
Implementation of a Customized Tertiary Analysis Platform for the Reporting of Somatic Variants.Biomarker insights · Jan 1, 2023
The My Cancer Genome clinical trial data model and trial curation workflow.Journal of the American Medical Informatics Association : JAMIA · Jul 1, 2020
Somatic Mutation Spectrum of Non-Small-Cell Lung Cancer in African Americans: A Pooled Analysis.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · Oct 1, 2015
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
operational efficiency
merging all assay and lab data into one report
clinical trial matching
real-time automated matching to 15,000+ active clinical trials
reporting acceleration
eliminating bottlenecks in molecular pathology workflows
Undisclosed
EHR Integration for automation from order to results
Automation from order to results
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from GenomOncology
Recent articles published on GenomOncology's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Precision Medicine & Genomics
Companies using AI to analyze genomic, proteomic, metabolomic, or multi-omics data to provide personalized treatment recommendations, identify genetic risks, or develop targeted therapies. Includes genomic sequencing platforms with AI analysis, preventive medicine based on genetic risk assessment, and longevity care based on molecular and genetic data.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.